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Abstract
Background: The study aimed to determine the frequency and characteristics of heart failure with
normal EF in a native African population with heart failure.
Methods: It was a hospital cohort study. Subjects were 177 consecutive individuals with heart
failure and ninety apparently normal control subjects. All the subjects underwent transthoracic
echocardiography. The group with heart failure was further subdivided into heart failure with
normal EF (EF ≥ 50) (HFNEF) and heart failure with low EF(EF <50)(HFLEF).
Results: The subjects with heart failure have a mean age of 52.3 ± 16.64 years vs 52.1 ± 11.84
years in the control subjects; p = 0.914. Other baseline characteristics except blood pressure
parameters and height were comparable between the group with heart failure and the control
subjects. The frequency of HFNEF was 39.5%. Compared with the HFLEF group, the HFNEF group
have a smaller left ventricular diameter (in diastole and systole): (5.2 ± 1.22 cm vs 6.2 ± 1.39 cm; p
< 0.0001 and 3.6 ± 1.24 cm vs 5.4 ± 1.35 cm;p < 0.0001) respectively, a higher relative wall thickness
and deceleration time of the early mitral inflow velocity: (0.4 ± 0.12 vs 0.3 ± 0.14 p < 0.0001 and
149.6 ± 72.35 vs 110.9 ± 63.40 p = 0.001) respectively.
The two groups with heart failure differed significantly from the control subjects in virtually all
echocardiographic measurements except aortic root diameter, LV posterior wall
thickness(HFLEF), and late mitral inflow velocity(HFNEF). HFNEF accounted for 70(39.5%) of cases
of heart failure in this study.
Hypertension is the underlying cardiovascular disease in 134(75.7%) of the combined heart failure
population, 58 (82.9%) of the subjects with HFNEF group and 76(71%) of the HFLEF group. Females
accounted for 44 (62.9%) of the subjects with HFNEF against 42(39.3%) in the HFLEF group (p =
0.002).
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Conclusion: The frequency of heart failure with normal EF in this native African cohort with heart
failure is comparable with the frequency in other populations. These groups of patients are more
likely female, hypertensive with concentric pattern of left ventricular hypertrophy.
Background
Congestive heart failure has been recognized from ancient
times [1]. The fact that heart failure remains a big problem
today is not surprising considering that it is the final path-
way of myriad of diseases that affect the heart[2-4]. Heart
failure constitutes a pandemic which has not spared any
group of people. In the western world where there are reli-
able epidemiological studies, the problem is grave indeed,
not only in terms of the high morbidity and mortality, but
also in terms of total cost to the different nations[5-7].
Even in the developing countries where not much data are
available, it is known that what is lacking in ischemic
heart disease- an almost exclusive preserve of the devel-
oped world, is made up for in hypertensive, diabetic and
infective heart diseases leading to heart failure[5,8-11]
It is recognised that there is a group of patients presenting
with the syndrome of congestive cardiac failure in the set-
ting of a normal ejection fraction[12,13]. The syndrome
in this group of patients known as diastolic heart failure is
believed to be due to impaired myocardial relaxation and
filling. There is therefore compensatory elevation of ven-
tricular filling pressures to maintain normal forward car-
diac output. The elevated left atrial pressure is transmitted
to the pulmonary vascular bed resulting in pulmonary
venous hypertension and its clinical manifestations
[12,14].
Although this entity has been challenged on the basis of
the presentation and symptomatology which is at least
similar to the features of other conditions common in the
elderly and, cardiovascular changes associated with aging
[15,16], studies have shown definite abnormalities in
diastolic function in patients fulfilling clinical criteria for
heart failure in the setting of preserved ejection fraction
[17-19]. This form of heart failure is also referred to as
heart failure with normal ejection fraction or heart failure
with preserved ejection fraction.
From previous studies, it is known that patients with heart
failure and normal ejection fraction are typically elderly,
often females, usually obese and frequently have hyper-
tension and diabetes [4]. This study aimed to determine
the pattern and the characteristics of heart failure with
preserved ejection fraction in subjects presenting to a ter-
tiary institution in Ibadan, Nigeria.
Methods
Study location
The study was carried out at the cardiology unit of the
department of medicine of the University College Hospi-
tal, Ibadan, Nigeria. The University College Hospital
Ibadan is the only tertiary health care facility located in
the city of Ibadan in south western Nigeria with more
than three million inhabitants.
Study population
Eligible patients were adult men and women aged 18
years and above, presenting with syndrome of heart fail-
ure. A total of 205 consecutive subjects with heart failure
were screened. 177 subjects were found eligible after
twenty one subjects were excluded on account of subopti-
mal echocardiographic image qualities and seven subjects
on account of co-existent chronic obstructive airway dis-
ease based on history or clinical examination or chest
radiograph. A second group consisted of ninety appar-
ently normal men and women who had no clinical his-
tory of cardiovascular or any other medical condition.
They were recruited from the medical (27 subjects, consti-
tuting 30%) and non-medical staff of the University Col-
lege Hospital Ibadan and patients' relations. The two
groups were comparable in their age and sex ratios.
Informed consent was obtained from all the study partic-
ipants before enrolment into the study. Ethical clearance
was obtained from the joint University of Ibadan and Uni-
versity College Hospital ethical committee.
Clinical evaluation
Diagnosis of congestive heart failure was based on the
Framingham's criteria for diagnosis of heart failure[20].
Major criteria were paroxysmal nocturnal dyspnoea,
orthopnoea, raised jugular venous pulse, lung crepita-
tions, cardiomegaly and gallop sounds. Minor criteria
were ankle oedema, night cough, dyspnoea on exertion,
hepatomegaly, pleural effusion and tachycardia.
Subjects were weighted without shoes and in light cloth-
ing on a standard beam balance. Height was measured to
the nearest centimetre using anthropometrical plane with
subjects not putting on shoes or headgear.
Body mass index (BMI) was calculated using the formula
BMI = Weight (kg)/(height)2 Body surface area was calcu-
lated using the formula of Dubois[21].BMC Cardiovascular Disorders 2009, 9:52 http://www.biomedcentral.com/1471-2261/9/52
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Diagnosis of heart failure with normal ejection fraction
required:
(1) Minimum of two major criteria or one major crite-
rion plus two minor criteria.
(2) Left ventricular ejection fraction (LVEF) equal to or
more than 50%.
Heart failure with reduced/low ejection fraction required
(1) above and LVEF < 50%.
Hypertension was deemed present if systolic BP ≥ 140
mmHg and or diastolic BP ≥ 90 mmHg[22,23] on at least
2 occasions or if patient was receiving anti-hypertensive
drug treatment. Diabetes mellitus was diagnosed based on
symptoms with Random blood sugar >200 mg/dl, fasting
blood sugar (FBS) >126 mg/dl (R) or subjects on hypogly-
caemic medications[24].
The BP was recorded in the right arm of subjects who have
rested for at least 5 minutes with an appropriately sized
cuff.
Coronary artery disease was considered present and a
cause of heart failure when there was evidence of definite
myocardial infarction from history, ECG or echocardio-
gram or if there is a long history of stable angina pectoris.
Valvular heart disease was considered the primary cause of
heart failure when there was echocardiographic evidence
of valvular heart disease of more than moderate severity.
Dilated cardiomyopathy was diagnosed based on dilated
cardiac chambers with increased left ventricular mass and
normal wall thickness
Echocardiogram was also employed to exclude pericardial
and congenital heart diseases.
Echocardiography
Echocardiography assessment was carried out with
ALOKA SSD - 1700 echo machine which was equipped
with a 3.5 MHz linear array transducer. Two dimensional
guided M-mode echocardiography was performed on
each subject in the left lateral decubitus position. All
measurements were made according to the American Soci-
ety of Echocardiography leading edge to leading edge cri-
teria[25]Average of measurements in three cardiac cycles
were taken with simultaneous ECG recording.
LV internal diameter and interventricular septal and pos-
terior wall thickness was measured at end diastole and
end systole. Left ventricular (LV) systolic performance was
assessed using the fractional shortening of the left ventri-
cle and the ejection fraction.
LV ejection fraction was calculated using the Teichholz
calculation formula[26].
Fractional shortening was calculated from LV internal
dimensions in diastole and systole
Left ventricular mass(LVM) was calculated using the
Devereux-modified ASE cube formular[27].
Where, VSTd is the ventricular septal thickness in diastole;
PWTd is the posterior ventricular wall thickness in dias-
tole and LVIDd is the left ventricular internal diameter in
diastole
Relative wall thickness(RWT) was calculated using[28].
The aortic root was measured at end diastole and the left
atrium was measured at end-ventricular systole, including
the thickness of the posterior wall of the aorta
Left ventricular diastolic function was evaluated by study-
ing the filling dynamics of the left ventricle. The mitral
inflow velocities were measured from the apical four
chamber view with pulsed-wave Doppler and with the
sample volume positioned at the tip of the mitral valve
leaflets. This inflow characteristics were quantified by
measuring the transmitral "E" wave velocity (peak early
mitral inflow velocity) and the "A" wave velocity (peak
atrial mitral inflow velocity), the E/A ratio and the decel-
eration time (DT):(time interval of Peak E wave velocity to
its extrapolation to the baseline) [29-31]. Two experi-
enced physicians blinded to the clinical data of the
patients carried out the echocardiographic studies.
Intraobserver concordance correlation coefficient varied
between 0.76 to 0.98 while interobserval concordance
varied between 0.82 to 0.96 in our laboratory.
Data management and statistical analysis
Statistical analysis was performed using SPSS software ver-
sion 10.0(SPSS, Inc. Chicago Illinois). Means were
expressed as means (standard deviation) while propor-
tions were expressed as count (percentages). Comparison
of categorical variables between the groups was by the chi
square test, while continuous variables were compared
LVIDd-LVIDs
LVIDd
×100
L V M V S T dP W T dL V I D d L V I D =× × + + − + 08 10 4 06
33 .( . ( )( ) . .
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using the students't' test for independent groups. Analysis
of variance was used to comparison of mean between 3 or
more groups. Non parametric tests were used where
appropriate. A two tailed p value < 0.05 was considered to
be significant.
Results
Table 1 shows the baseline characteristics of all the 267
adult Nigerians comprising 177 subjects (patients with
clinical features of congestive cardiac failure) and 90
(apparently healthy) subjects in the control group, who
were recruited into the study. There was no significant dif-
ference in the age, gender distribution or weight but the
control subjects were taller. The systolic blood pressure
and mean arterial pressure were higher in the subjects
with heart failure but the other blood pressure parameters
were comparable.
Stratifying the subjects with heart failure into 2 groups
based on whether the ejection fraction is preserved or
reduced and comparing with control subjects (table 2),
reveals a comparable mean age between the three groups.
The group with normal ejection fraction had more
females, a higher systolic blood pressure, pulse pressure
and body mass index compared with both the subjects
with reduced ejection fraction and the control subjects.
The diastolic blood pressure and mean arterial pressure
are comparable among the three groups. Heart failure
with normal ejection fraction accounted for 39.5% of the
subjects with heart failure with the rest accounted for by
heart failure with reduced ejection fraction.
Hypertension was the most frequent underlying cardio-
vascular disease across all the heart failure groups. Hyper-
tension was present in 75.7% of the combined heart
failure group, 71% of the group with heart failure and
reduced EF and 82.9% of the group with heart failure with
normal EF.
Dilated cardiomyopathy accounted for 13.6% of the
underlying cardiovascular factors. Valvular heart disease,
mainly rheumatic was found in 7.9% of the heart failure
subjects. Ischaemic and restrictive heart disease accounted
for 1.7% and 0.6% of the cases respectively. The only case
of restrictive heart disease was histologically confirmed to
be due to amyloidosis. Eleven subjects were found to have
Diabetes mellitus. All the subjects with diabetes also had
hypertension.
Table 3 shows the analysis of variance of the echocardio-
graphic parameters of the subjects with heart failure and
the controls. The 2 groups with heart failure have compa-
rable left atrial size, septal and posterior wall dimensions
but a trend towards a higher indexed left ventricular mass
in the group with reduced ejection fraction. The group
with reduced ejection fraction had a wider LV dimension
both in systole and diastole and a lower relative wall
thickness. Apart from aortic root dimension(both groups
with heart failure), posterior wall thickness in dias-
tole(group with reduced EF), relative wall thick-
ness(group with normal EF) which are comparable with
the control group, the heart failure group differed signifi-
cantly from the control group in measure of left ventricu-
lar geometry.
Table 1: Baseline characteristics of the Subjects
Variables Heart failure
N = 177
Controls
N = 90
P value
Age 52.3(16.64) 52.1(11.84) 0.914
Gender(m/f) 91/86 42/48 0.610
Weight 67.4(16.11) 69.2(14.55) 0.401
Height 162.3(10.73) 164.9(8.22) 0.040
BMI 26.9(4.55) 25.5(5.31) 0.545
SBP 125.4(23.53) 119.6(8.49) 0.004
DBP 79.6(16.06) 77.1(7.72) 0.090
PP 45.5(20.48) 42.4(7.37) 0.073
MAP 94.3(17.71) 91.3(7.20) 0.047
BMI = Body mass index, SBP = Systolic blood pressure, DBP = 
Diastolic blood pressure, PP = Pulse pressure, MAP = Mean arterial 
blood pressure.
Table 2: Analysis of variance of the 2 groups of subjects with heart failure and the control subjects
Variables HFLEF(A)
N = 107
HFNEF(B)
N = 70
Controls(C)
N = 90
P value P value A vs B P value A vs C P value
B vs C
Age 51.1(15.78) 54.2(17.83) 52.1(11.84) 0.385 0.540 0.931 0.788
Gender 65/42 25/44 48/42 0.010 - - -
Weight 65.2(12.09) 70.8(20.39) 69.2(14.55) 0.051 0.121 0.125 0.918
Height 164.0(8.20) 159.6(13.31) 164.9(8.22) 0.003 0.043 0.833 0.012
BMI 24.2(4.00) 30.9(4.152) 25.5(5.31) 0.004 0.001 0.886 0.090
SBP 121.0(22.29) 132.2(23.89) 119.6(8.49) <0.0001 <0.0001 0.910 <0.0001
DBP 80.2(17.17) 78.8(14.30) 77.1(7.72) 0.274 0.918 0.283 0.767
PP 40.4(19.23) 53.4(19.98) 42.4(7.37) <0.0001 <0.0001 0.685 <0.0001
MAP 92.9(19.03) 96.6(15.43) 91.3(7.20) 0.041 0.404 0.806 0.028
HFNEF = Heart failure with normal ejection fraction, HFLEF = Heart failure with low ejection, BMI = Body mass index, SBP = Systolic blood 
pressure, DBP = Diastolic blood pressure, PP = Pulse pressure, MAP = Mean arterial blood pressure.BMC Cardiovascular Disorders 2009, 9:52 http://www.biomedcentral.com/1471-2261/9/52
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The group with heart failure and reduced EF had a reduced
deceleration time of early transmitral flow velocity (E).
Otherwise measures of transmitral flow are comparable
between the 2 groups. Compared with the control sub-
jects, both groups have higher early mitral inflow velocity
(E) and higher ratio of early inflow velocity to the atrial
mitral inflow velocity (E/A ratio) and a lower deceleration
time of early transmitral flow velocity (E). Additionally,
the group with reduced EF have a lower late transmitral
flow velocity (A).
Discussion
The study showed that patients presenting in heart failure
are more likely to have a higher left ventricular mass,
thicker septum and more dilatation of the left atrium and
the left ventricle when compared with normal subjects. It
also showed that subjects with heart failure and preserved
ejection fraction and subjects with reduced EF have com-
parable left ventricular wall thickness and left atrial dilata-
tion. The major differences between these 2 groups are
more LV dilatation and reduced deceleration time of E in
the subjects with reduced EF. Heart failure with normal
ejection fraction occurred in one out of every three heart
failure patients. Hypertension was the most frequent
underlying cardiovascular disease associated with heart
failure and also heart failure with preserved ejection frac-
tion in this African population of subjects with heart fail-
ure.
In the study the mean age of patients with heart failure
was 52.3 ± 16.6 years which is comparable with the find-
ings in previous studies by Falase et al[9] over 2 decades
ago and recently by Oyati et al[32] in similar racial
groups. The age is higher in Caucasian studies. Senni et al
[20] reported mean age of 77.3 ± 12.1 years and Cowie et
al[3] reported a median age of 76-78 years for women and
men in studies among Caucasian subjects. This trend is
consistent for studies in Caucasian populations. Agoston
et al [33] comparing black and white subjects with heart
failure found that blacks and whites with preserved ejec-
tion fraction had comparable age while blacks with
reduced ejection fraction were younger. The differences
found in the studies are most likely due to a combination
of differences in race: white vs black and environmental
influences since Africans in diaspora did not show exactly
same characteristics with the native Africans in this study.
The mean age of the group presenting with heart failure
and normal ejection fraction and the group presenting
with reduced ejection fraction was not significantly differ-
ent. This finding is similar to previous studies in Cauca-
sian populations by Varela-Roman et al[34] and Senni et
al[20] who compared patients with normal EF with those
who had reduced EF. There was a female predominance in
the group with preserved EF. Females accounted for
62.9% of the subjects with normal EF against 39.3% in the
group with reduced EF (p = 0.002). Female preponder-
ance in subsets with heart failure and normal EF has been
consistent in the few studies that have attempted to deter-
mine gender differences. For instance Vasan et al[2]
reported that 65% of patients who presented with normal
ejection fraction were women in a case control study.
Heart failure with normal ejection fraction was found in
39.5% of the patients who presented in heart failure in
our study. This figure is comparable with the figure of 40-
71% quoted in previous studies in other populations[35].
Table 3: Echocardiographic parameters of the subjects
Variables HFNEF(A)
n = 70
HFLEF(B)
n = 107
Controls(C)
n = 90
ANOVA P-value P value A vs B P value
A vs C
P value
B vs C
LA(cm) 4.2(1.03) 4.8(1.0.99) 3.1(0.43) <0.0001 0.540 <0.0001 <0.0001
AORTA(cm) 2.8(0.82) 2.8(0.604) 2.8(0.38) 0.403 0.858 0.966 0.936
IVSTd(cm) 1.09(0.277) 1.04(0.301) 0.88(0.14) <0.0001 0.486 <0.0001 <0.0001
PWTd(cm) 0.95(0.21) 0.91(0.27) 0.87(0.13) 0.0413 0.531 0.025 0.578
LVIDd(cm) 5.2(1.22) 6.2(1.39) 4.5(0.54) <0.0001 <0.0001 <0.0001 <0.0001
LVIDs(cm) 3.6(1.24) 5.4(1.35) 2.9(0.48) <0.0001 <0.0001 <0.0001 <0.0001
RWT 0.4(0.12) 0.3(0.14) 0.4(0.07) <0.0001 <0.0001 0.777 <0.0001
LVM/HT2.7(g/m2.7) 50.8(20.93) 55.6(21.6) 29.6(10.08) <0.0001 0.063 <0.0001 <0.0001
FS (%) 31.6(10.35) 12.5(4.74) 35.9(7.29) <0001 <0.0001 0.012 <0.0001
EF (%) 65.5(11.22) 32.0(11.03) 72.7(8.57) <0.0001 <0.0001 <0.0001 <0.0001
E(m/s) 0.7(0.39) 1.1(0.72) 0.6(0.16) <0.0001 0.964 0.028 0.006
A(m/s) 0.5(0.25) 0.4(0.24) 0.5(0.14) 0.021 0.081 0.985 0.002
E/A 1.7(1.01) 2.1(0.91) 1.3(0.39) <0.0001 0.117 0.003 <0.0001
DT(ms) 149.6(72.35) 110.9(63.40) 178.6(41.13) <0.0001 0.001 0.011 <0.0001
HFNEF = Heart failure with normal ejection fraction, HFLEF = Heart failure with low ejection, LA = Left atrium, IVSd = Interventricular septal wall 
thickness in diastole, PWTd = Posterior wall thickness in diastole, LVIDd = Left ventricular internal diameter in diastole, RWT = Relative wall 
thickness, LVM = Left ventricular mass, HT = Height, FS = Fractional shortening, EF = Ejection fraction, E = Early filling velocity, A = Late filling 
velocity, DT = Deceleration timeBMC Cardiovascular Disorders 2009, 9:52 http://www.biomedcentral.com/1471-2261/9/52
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The systolic blood pressure and pulse pressure were signif-
icantly different between the group with normal ejection
fraction and the group with reduced ejection fraction.
These parameters were higher in the former. These find-
ings are consistent with the fact that hypertension was
found to be a more frequent aetiology of heart failure in
the group with normal ejection fraction than in the group
with reduced ejection fraction. Also, a narrow pulse pres-
sure is an expected accompaniment of the low ejection
fraction characterising heart failure with low EF. Ahmed et
al [36] had demonstrated a distinct relationship between
higher systolic blood pressure and heart failure with pre-
served ejection fraction.
Left ventricular geometry
Comparing the heart failure groups, it was found that the
end diastolic diameter, end systolic diameters were signif-
icantly larger in the group with low ejection fraction,
while expectedly the relative wall thickness was higher in
the group with preserved ejection fraction. Distinct rela-
tionship between left ventricular dilatation and poor
systolic function is well established. Devereux et al[37]
and Tsutsui et al[38] also documented that the patients
with reduced ejection fraction tended to have relatively
thinner walls and more dilated ventricles when compared
with the group with normal ejection fraction that tended
to have a more concentric hypertrophy pattern.
Diastolic dysfunction
The shorter deceleration time(DT) in the group with heart
failure and reduced ejection fraction is similar to the find-
ings by Devereux et al[37]. This is likely due to the
expected natural history of the failing heart in which at the
later stages of severe heart failure there is increasing
restrictive left ventricular filling. The higher mitral E veloc-
ity and E/A ratio in the two groups with heart failure when
compared with the control subjects and the lower trans-
mitral A velocity demonstrable only in the group with low
ejection fraction is in support of the postulation that heart
failure occur as a spectrum of abnormalities beginning
from diastolic dysfunction and only mild systolic dysfunc-
tion detectable only by more sensitive modalities, pro-
gressing to the extreme of severe systolic and diastolic
dysfunction. The finding by Kitzman et al[39], of no sig-
nificant difference between the mitral inflow characteris-
tics of the group with heart failure and normal EF and the
group with reduced EF, further strengthens the position
that the diastolic dysfunction may also be mild initially. It
is very likely that more sensitive modalities or multiple
modalities for assessing diastolic dysfunction would have
demonstrated at least some degree of diastolic abnormal-
ities in these patients. The body mass index was higher in
the subset of patients with heart failure and normal EF.
This is consistent with findings from previous studies[4].
The relationship between obesity and hypertension and
diastolic dysfunction may be responsible for this finding.
Aetiology of heart failure
Hypertension was the overall leading cause of heart fail-
ure in this study. Furthermore hypertension was impli-
cated even more frequently in patients with preserved
ejection fraction. This is consistent with the findings in
some other populations [40,41]. The implication is that
although hypertension is the commonest cause of heart
failure among black Africans[42,9], its definite relation-
ship with heart failure with normal ejection fraction is
obvious still. The spectrum of underlying cardiovascular
diseases in this study when compared with a previous
study by Senni et al[20], showed a similarity in the range
of aetiological factors for heart failure as a whole, except
for the prominence of ischaemic heart disease and the
absence of valvular heart disease in their study carried out
in a predominantly Caucasian population. When they
compared the underlying cardiovascular disease in the
group with normal ejection fraction and the group with
reduced ejection fraction, hypertension was the most fre-
quent factor in the two groups. This trend is similar to the
findings in this study. The difference is that hypertension
may be a much more important underlying factor for
heart failure in native African populations.
Although there is considerable debate whether HFNEF
can evolve into HFLEF, we are of the view that in Africa
where hypertension is the main aetiology, this may be the
case. Some studies have suggested this in other popula-
tions and there is need to study the natural history HFNEF
in native Africans [43-45].
Limitation of the study
The study, a hospital based, carried out in a single centre
might not be completely representative of the findings in
the community or in other centres, hence a multicentred
and/or community based study would be desirable to
fully characterise heart failure with preserved EF in this
population group.
Use of other modalities of assessing diastolic function
such as pulmonary venous flow velocities, tissue Doppler
echocardiography or invasive measurements could have
helped to further establish and characterise diastolic dys-
function in this study population. These were not
included in the study protocol.
We also recognise the use of Teicholtz formula rather than
the modified Simpson's method in the assessment of the
ejection fraction (in the presence of ventricular dilatation)
as a limitation of the studyBMC Cardiovascular Disorders 2009, 9:52 http://www.biomedcentral.com/1471-2261/9/52
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Conclusion
Heart failure with normal ejection fraction constitutes a
significant part of the heart failure burden in this native
African cohort and the frequency of 39.5% found in this
study is comparable with findings in other populations.
Hypertension was the most common underlying cardio-
vascular condition overall and in the different heart fail-
ure groups, the highest relative frequency being in the
group with heart failure and normal ejection fraction.
Patients with heart failure and normal ejection fraction
are more likely female with higher body mass index, wider
pulse pressure, thicker septum, and a more concentric pat-
tern of hypertrophy when compared with the group with
reduced ejection fraction.
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